Terms: = Breast cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4
90360 results:
1. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
[TBL] [Abstract] [Full Text] [Related]
2. Exploring Guolin Qigong (Mind-Body Exercise) for Improving cancer Related Fatigue in cancer Survivors: A Mixed Method Randomized Controlled Trial Protocol.
Low SLK; Ho GF; Liu B; Koh ES; Fei Y; Teo CS; Zhu X
Integr Cancer Ther; 2024; 23():15347354241252698. PubMed ID: 38757745
[TBL] [Abstract] [Full Text] [Related]
3. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
4. Evaluating the effects of various ethanolic medicinal plant extracts on metastatic breast cancer proliferation, invasion, and expression of a novel potential drug target; CD82 metastatic suppressor protein, and on in vivo angiogenesis using the ex ovo yolk sac membrane (YSM) assay.
Loggenberg S; Twilley D; Lall N
J Cancer Res Clin Oncol; 2024 May; 150(5):257. PubMed ID: 38753184
[TBL] [Abstract] [Full Text] [Related]
5. A pilot randomised controlled trial of acceptance and commitment therapy for medication decision-making and quality of life in women with breast cancer: The ACTION trial.
Graham CD; Ellison R; Hall LH; Clark J; McNaught E; Green SMC; Wilkes H; Robson G; Lorentz I; Holmes L; Bould N; Hartley S; Naik J; Buckley S; Hirst C; Hartup S; Foy R; Neal RD; Velikova G; Farrin A; Collinson M; Smith SG
Psychooncology; 2024 May; 33(5):e6349. PubMed ID: 38752788
[TBL] [Abstract] [Full Text] [Related]
6. Dietary supplement intake in women with breast cancer before and after diagnosis: results from the SUCCESS C trial.
Hauner D; Mang A; Donik L; Schederecker F; Meyer D; Rack B; Janni W; Hauner H
BMC Cancer; 2024 May; 24(1):591. PubMed ID: 38750410
[TBL] [Abstract] [Full Text] [Related]
7. Practice of breast self-examination and associated factors among women of reproductive age in the North Shoa Zone, Oromia, Ethiopia, 2022: a convergent mixed-methods study.
Hussein D; Oyato BT; Gashaw K; Geleta TA; Tufa DG; Geleta LA
BMJ Open; 2024 May; 14(5):e073951. PubMed ID: 38749697
[TBL] [Abstract] [Full Text] [Related]
8. Association between red cell distribution width and all-cause mortality in patients with breast cancer: A retrospective analysis using MIMIC-IV 2.0.
Xiao J; Tan L; Pei Y; Yang R; Li J; Feng Y; Feng J
PLoS One; 2024; 19(5):e0302414. PubMed ID: 38748743
[TBL] [Abstract] [Full Text] [Related]
9. A meta-analysis of MRI radiomics-based diagnosis for BI-RADS 4 breast lesions.
Lin J; Zheng H; Jia Q; Shi J; Wang S; Wang J; Ge M
J Cancer Res Clin Oncol; 2024 May; 150(5):254. PubMed ID: 38748373
[TBL] [Abstract] [Full Text] [Related]
10. Posttranslational protein modifications as gatekeepers of cancer immunogenicity.
Marchese E; Demehri S
J Clin Invest; 2024 May; 134(10):. PubMed ID: 38747288
[TBL] [Abstract] [Full Text] [Related]
11. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
Zhang X; Teng X; Zhang J; Lai Q; Cai J
Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
[TBL] [Abstract] [Full Text] [Related]
12. Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.
Romaní-Cubells E; Martínez-Erro S; Morales V; Chocarro-Calvo A; García-Martínez JM; Sanz R; García-Jiménez C; García-Muñoz RA
J Nanobiotechnology; 2024 May; 22(1):249. PubMed ID: 38745193
[TBL] [Abstract] [Full Text] [Related]
13. An Immersive Virtual Reality Intervention for Preoperative Anxiety and Distress Among Adults Undergoing Oncological Surgery: Protocol for a 3-Phase Development and Feasibility Trial.
El-Gabalawy R; Sommer JL; Hebbard P; Reynolds K; Logan GS; Smith MSD; Mutter TC; Mutch WA; Mota N; Proulx C; Gagnon Shaigetz V; Maples-Keller JL; Arora RC; Perrin D; Benedictson J; Jacobsohn E
JMIR Res Protoc; 2024 May; 13():e55692. PubMed ID: 38743939
[TBL] [Abstract] [Full Text] [Related]
14. Comparison efficacy and safety of acupuncture and moxibustion therapies in breast cancer-related lymphedema: A systematic review and network meta-analysis.
Xu Y; Yu J; Shen R; Shan X; Zhou W; Wang J
PLoS One; 2024; 19(5):e0303513. PubMed ID: 38743748
[TBL] [Abstract] [Full Text] [Related]
15. Survival Patterns Among Patients With breast cancer in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Limenih MA; Mekonnen EG; Birhanu F; Jima BR; Sisay BG; Kassahun EA; Hassen HY
JAMA Netw Open; 2024 May; 7(5):e2410260. PubMed ID: 38743426
[TBL] [Abstract] [Full Text] [Related]
16. [Impact of changes in malignant tumor death spectrum on life expectancy in Tianjin residents from 1999-2019].
Jiang TT; Wang SY; Yin XL; Xu JH; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):461-470. PubMed ID: 38742360
[No Abstract] [Full Text] [Related]
17. Clinicopathological characteristics and BRCA1/brca2 pathogenic variants of patients with breast cancer.
Eras N; Tuncel F; Altıntas Z; Erden S
Pol J Pathol; 2024; 75(1):1-7. PubMed ID: 38741424
[TBL] [Abstract] [Full Text] [Related]
18. Genome-wide association analyses of breast cancer in women of African ancestry identify new susceptibility loci and improve risk prediction.
Jia G; Ping J; Guo X; Yang Y; Tao R; Li B; Ambs S; Barnard ME; Chen Y; Garcia-Closas M; Gu J; Hu JJ; Huo D; John EM; Li CI; Li JL; Nathanson KL; Nemesure B; Olopade OI; Pal T; Press MF; Sanderson M; Sandler DP; Shu XO; Troester MA; Yao S; Adejumo PO; Ahearn T; Brewster AM; Hennis AJM; Makumbi T; Ndom P; O'Brien KM; Olshan AF; Oluwasanu MM; Reid S; Butler EN; Huang M; Ntekim A; Qian H; Zhang H; Ambrosone CB; Cai Q; Long J; Palmer JR; Haiman CA; Zheng W
Nat Genet; 2024 May; 56(5):819-826. PubMed ID: 38741014
[TBL] [Abstract] [Full Text] [Related]
19. Diabetes-related risk factors and survival among individuals with type 2 diabetes and breast, lung, colorectal, or prostate cancer.
Laurberg T; Witte DR; Gudbjörnsdottir S; Eliasson B; Bjerg L
Sci Rep; 2024 May; 14(1):10956. PubMed ID: 38740921
[TBL] [Abstract] [Full Text] [Related]
20. Pradimicin U, a promising antimicrobial agent isolated from a newly found Nonomuraea composti sp. nov.
Duangupama T; Pittayakhajonwut P; Intaraudom C; Suriyachadkun C; Tadtong S; Kuncharoen N; He YW; Tanasupawat S; Thawai C
Sci Rep; 2024 May; 14(1):10942. PubMed ID: 38740839
[TBL] [Abstract] [Full Text] [Related]
[Next]